Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers behind the Oxford AstraZeneca coronavirus vaccine have been recognised for their excellence at a healthcare awards ceremony.

NHS Parliamentary Awards; The Excellence in Healthcare Award Winner: Oxford Vaccine Group and Jenner Institute

The teams who worked to develop the jab in record time were among the winners at this year’s NHS Parliamentary Awards.

The Oxford Vaccine Group and the Jenner Institute were honoured with the award for excellence in healthcare.

They were among 10 winners selected from more than 700 nominations and announced during a ceremony in London on Wednesday.

Others to be recognised included health teams who created ways for people to keep in touch with their loved ones in hospital during the pandemic and another behind “pop up” clinics to diagnose and treat Hepatitis C among homeless people in Leeds.

Speaking in a video message for the event, Prime Minister Boris Johnson paid tribute to the NHS as “the beating heart of Britain”.

Thanking health and social care workers, he said: “We cherish the extraordinary devotion of all those who serve – the army of doctors and nurses, ambulance crews, cleaners, porters, physios, radiographers pharmacists, midwives, maternity assistants and so many more – you’ve kept coming to work and kept yourselves in harm’s way to save thousands of lives throughout this pandemic.

“These awards are so important because they tell the story of that extraordinary service, 24 hours a day, every second of every hour.

“From pioneering the Oxford AstraZeneca vaccine, delivering the fastest and biggest immunisation programme in our history, to comforting worried relatives unable to visit their loved ones and delivering virtual remote care for many in our communities, these awards celebrate the innovation and compassion with which you met unique challenges of this moment.”

The winners were chosen by a national panel made up of senior leaders representing both staff and patients.

NHS chief executive Sir Simon Stevens said: “All of the nominees put forward for an award this year have done incredible work, and it is a great honour to be able to award our winners with the recognition they deserve for their incredible service to us all.”

The full list of winners were:

– Oxford Vaccine Group and Jenner Institute – Excellence in Healthcare Award

– Critical Care Family Liaison Team, University Hospitals Birmingham NHS Foundation Trust – Care and Compassion Award

– The Life Rooms, the North West – Excellence in Mental Health Care Award

– Sussex GP Dr Bruce Allan – Excellence in Primary Care Award

– London Ambulance Service Macmillan End of Life Care Programme Team – Excellence in Urgent and Emergency Care Award

– The North Middlesex University Hospital’s Sunrise Neonatal Team – Future NHS Award

– Leeds Street Outreach Initiative for Hepatitis C – Health Equalities Award

– The University Hospitals of Morecambe Bay Black, Asian and Minority Ethnic Staff Network – Wellbeing at Work Award

– Dr Rajiv Sethi, junior doctor in the North West of England – NHS Rising Star

– Joe Sim, an 80-year-old grandfather and engineer and energy monitor for University Hospitals of Derby and Burton NHS Foundation Trust – Lifetime Achievement Award

Similar stories

Mixed Oxford/Pfizer vaccine schedules generate robust immune response against COVID-19, finds Oxford-led study

Alternating doses of the Oxford-AstraZeneca and Pfizer-BioNTech vaccines generate robust immune responses against COVID-19, according to researchers running the University of Oxford-led Com-COV study.

Delayed second dose and third doses of the Oxford-AstraZeneca vaccine lead to heightened immune response

Research on the ChAdOx1 nCoV-19, also known as the Oxford-AstraZeneca vaccine, indicates that a long interval between first and second doses does not compromise the immune response after a late second dose.

First trial participants vaccinated with Oxford COVID-19 variant vaccine

The University of Oxford in partnership with AstraZeneca began vaccinations on 27 June 2021 for a new phase in human trials to test a COVID-19 vaccine ‘AZD2816’ in volunteers against the B.1.351 variant of concern – commonly known as the Beta variant.

Oxford researchers identify levels of antibody protection required to prevent symptomatic COVID-19

Researchers from the University of Oxford have today released their findings about the so-called ‘correlates of protection’ against symptomatic COVID-19; potentially a tool to speed up safe development of new vaccines which may assist regulators in assessing the likely potency of any new COVID-19 vaccine without the need for Phase III efficacy trial data.

Latest data on immune response to COVID-19 reinforces need for vaccination, says Oxford-led study

A new study led by the University of Oxford has found that previous infection, whether symptomatic or asymptomatic, does not necessarily protect you long-term from COVID-19, particularly against new Variants of Concern.

OVG's director recognised in Queen’s Birthday Honours

Andrew Pollard, Director of the Oxford Vaccine Group, and Professor of Paediatric Infection and Immunity, becomes a Knight Bachelor for services to Public Health, particularly during the COVID-19 Pandemic.